Glaucoma Trial, Recruiting NCT05136950 Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT05136950
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 18 months and 14 years of age
  • Children who were diagnosed with a cataract present from birth (a clouding of the lens in the eye that a child is born with)
  • Children who had surgery to remove that cataract when they were between 2 and 24 months old

Who may not be able to join:

  • Children who had an artificial lens (called an IOL) placed in the eye at the same time as the original cataract removal surgery
  • Children who have another pre-existing eye condition that could affect where or how an artificial lens might be placed later, such as an unusually small eye, clouding of the clear front part of the eye, certain iris (coloured part of the eye) abnormalities, glaucoma (raised pressure in the eye) that was diagnosed before the cataract surgery, ongoing eye inflammation, abnormal blood vessel growth in the eye, or eye injury (confirm with trial site for the full list)
  • Children whose artificial lens placement would need to be secured with stitches/sutures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yizhi Liu, PhD, Zhongshan Ophthalmic center, Guangzhou, People's Republic of China

Phone: +86 13570382241

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Registry
ClinicalTrials.gov
Start date
14 December 2021
Est. completion
30 July 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of glaucoma-related adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov